The precise molecular mechanisms underlying priapism associated with sickle cell disease remain to be defined. However, there is increasing evidence that up-regulated activity of the opiorphin and adenosine pathways in corporal tissue, resulting in heighted relaxation of smooth muscle, play an important role in development of priapism. A key enzyme in the adenosine pathway is CD73, an ecto-5-prime-nucleotidase (5-prime-ribonucleotide phosphohydrolase; EC 3.1.3.5) which catalyzes the conversion of adenosine mononucleotides to adenosine. In the present study we investigated how sickle cell disease and hypoxia regulate the interplay between opiorphin and CD73. In the corpora of sickle cell mice we observed significantly elevated expression of both the mouse opiorphin homologue mSmr3a (14-fold) and CD73 (2.2-fold) relative to non-sickle cell controls at a life-stage prior to the exhibition of priapism. Sickle cell disease has a pronounced hypoxic component, therefore we determined if CD73 was also modulated in in vitro corporal smooth muscle (CSM) models of hypoxia. Hypoxia significantly increased CD73 protein and mRNA expression by 1.5-fold by and 2-fold, respectively. We previously demonstrated that expression of another component of the adenosine signaling pathway, the adensosine 2B receptor, can be regulated by sialorphin (the rat opiorphin homolologue), and we demonstrate that sialorphin also regulates CD73 expression in a dose and time dependent fashion. Using siRNA to knock-down sialorphin mRNA expression in CSM cells in vitro, we demonstrate that the hypoxic up-regulation of CD73 is dependent on the upregulation of sialorphin. Overall our data provides further evidence to support a role for opiorphin in CSM in regulating the cellular response regulating response to hypoxia or sickle cell disease by activating smooth muscle relaxant pathways.
INTRODUCTION
Priapism is a prolonged penile erection which can result in tissue damage and erectile dysfunction. The condition is often associated with patients with sickle cell disease, where 29-42% of patients report a priapic episode during their life time (1) . The molecular mechanisms involved in the development of priapism are complex and poorly understood which to date has prevented the development of any effective pharmacological intervention for its prevention or treatment. Understanding the association between different pathways resulting in priapism may lead to novel pharmacological strategies for its treatment.
Penile erection is a neurovascular process in which relaxation of the corporal smooth muscle (CSM) tissue allows increased blood flow into the penis (2) . Erectile dysfunction (ED) results when the biochemical pathways mediating CSM relaxation are perturbed, and priapism results when relaxant pathways are excessively activated. Pioneering work conducted in 1992 established a central role for nitric oxide (NO) as a physiologic mediator of penile erection (3) .
Although NO remains recognized as the principal mediator of CSM relaxation (3, 4) , several other signaling pathways are known to play a role in relaxing of CSM and thereby are potentially involved in erectile function and priapism. Recently, adenosine (5) and opiorphin (6, 7) signaling pathways have received attention as possible mediators of excessive CSM relaxation that result in priapism.
Adenosine has been implicated in the regulation of penile erection almost as long as NO (8) . The adenosine signaling pathways were shown to potentially play a role in priapism when mice lacking adenosine deaminase (ADA), an enzyme necessary for the breakdown of adenosine, displayed unexpected priapic activity (9) . In mouse models which mimic the priapic condition associated with human sickle cell disease, mouse corporal tissue exhibited elevated adenosine levels and adenosine 2B receptor (A2B) expression (9) . It has recently been suggested that excess adenosine A2B receptor signaling both in sickle cell and ada -/-mice models contributes to priapism through a mechanism in which there is Hif-1a mediated reduction of PDE5 gene expression (10) .
Adenosine is derived from extracellular adenine nucleotides which are dephosphorylated by an ectonucleotidase (CD39), which hydrolyzes ATP to ADP and ADP to AMP. CD73 an ecto-5′-nucleotidase (also known as 5-prime-ribonucleotide phosphohydrolase; EC 3.1.3.5) then catalyzes the dephosphorylation of AMP to adenosine and is generally the rate-limiting step in the formation of adenosine from extracellular adenine nucleotides. Histological analysis has demonstrated that CD73 is widely expressed in penile tissue, with remarkably high levels in the nerve bundles, smooth muscle, and endothelium (11) . Additional genetic and pharmacological studies demonstrate that CD73-mediated adenosine production contributes to the initiation and maintenance of penile erection following cavernous nerve stimulation (11) .
In contrast to adenosine and NO, evidence for the involvement of opiorphins in penile erection is relatively recent. The opiorphins were shown to be amongst the most down-regulated genes in corporal tissue from animal models of ED (12, 13) and are also down regulated in the corpora of patients with ED (14) . Overexpression of opiorphins by gene transfer has been shown to cause a priapic-like condition in rat models and the opiorphin genes of mice are significantly up-regulated in the corporal tissue of sickle cell mice compared to controls (6) . It was recently proposed that up-regulation of opiorphins in corporal tissue might occur as a response to low levels of oxygen resulting from sickle cell disease (7) . Although the opiorphins can directly mediate CSM relaxation (15) they also appear to be involved in regulation of gene expression that may be involved in smooth muscle relaxation pathways, such as HIF-1a, A2BR(7), G-protein coupled receptors and members of the ornithine decarboxylase pathway (6, 16) .
Given that both opiorphin and CD73 appear to play an important role in development of priapism in the present study, we studied their potential inter-relationship and factors that may regulate their expression in sickle cell disease.
MATERIALS AND METHODS

Animals, cell isolation and culture
Five-week old Berk transgenic sickle cell mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). They were maintained in the Albert Einstein Animal Facility till the life stage to be investigated (5 and 12 weeks old). Age-matched C57BL/6 animals were used as controls. Numbers of animals for each experiment are described in figure legends.
For preparation of CSM cells, corpus cavernosum tissue was harvested from 8-week-old male Sprague-Dawley rats (Charles River, Wilmington, MA, USA) under euthanasia. After dissection and removal of the urethra, the corpus cavernosum tissues were obtained excluding the glans, cartilaginous portion of the penis, and the part of overlying ischiocavernous muscle.
The corpus cavernosum tissue was washed in phosphate-buffered saline (PBS) several times.
The sample was cut into fragments. The tissue fragments were then placed in culture dish and incubated for 10 days. The sprouting cells were subcultured in Dulbecco's modified eagle medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 g/ml streptomycin. All animal studies were approved by the Institute of Animal Studies at Albert Einstein College of Medicine.
Chemicals
Sialorphin (Sigma, St. Louis, USA) was dissolved in H 2 O at concentration of 10 mM and stored at −20°C until use.
Establishment of in vitro hypoxic conditions
In order to cause in vitro chemical hypoxia CoCl 2 was added to DMEM to a final concentration of 100Mol as previously described (17, 18) . Hypoxic conditions due to low oxygen levels was induced by culture of CSM cells in 1% O 2 , 5% CO 2 , and 94% N 2 in a 95% humidified atmosphere as previously described (19) Quantitative RT-PCR
The total RNA was extracted from frozen tissue with TRIzol according to the manufacturer's instruction. Briefly, ≈ 50 mg tissue was added to 1 mL of TRIzol reagent and homogenized using a polytron homogenizer (Brinkman, Westbury, NY, USA) for 30 s. The homogenized tissues were incubated for 5 min at room temperature followed by adding 200 μL of chloroform. After mixing, the aqueous phases were separated by centrifugation (12,000 g for 15 min) at 4°C and then were transferred to a clean tube. The RNA was precipitated from the aqueous phase by addition of isopropyl alcohol and pelleted by centrifugation at 12,000g for 10 min at 4°C, washed once with 75% ethanol, and again pelleted at 7,500 g for 5 min. Then ethanol was aspirated and the RNA pellet was dissolved in sterile water; 4 μg of total RNA was reverse-transcribed to firststrand cDNA primed with Oligo(dT) using the Superscript (Invitrogen) First-Strand Synthesis
System for real-time PCR. RNA was denatured for 5 min at 65°C and immediately cooled on ice. Then RNA was combined with reaction buffer and DTT for min at 42°C, then RNA was combined with Superscript II RT. cDNA was synthesized for 50 min at 42°C, then terminate the reaction at 70 for 15min and chill the samples on ice. RT products then were amplified using Sybr Green 2 ×PCR Master Mix (PE Applied Biosystems, Warrington, UK). Real-time quantitative PCR analysis was performed using the 7300 real-time PCR system (Applied Biosystems, Foster City, CA, USA). The primers used are described in Table 1 Ct method ).
RESULTS
In corporal tissue of sickle cell mice there is up-regulation of genes encoding the mouse opiorphin homologues and CD73.
In order to understand the co-regulation of opiorphins and adenosine pathways we compared gene expression of the mouse opiorphin homologues (mSmr3a and mSmr2) with CD73 in the corpora of sickle cell mice to controls at a life stage which does not exhibit any physiological evidence of priapism (5-weeks old), and at a later life stage (12-weeks) when mice have been shown to present physiological evidence of priapism (6) ( Figure 1A ). There was up-regulation of the opiorphin homologue mSmr3a and CD73 (14-fold and 2.2-fold, respectively) in the corporal tissue of a 5-week old sickle cells animal compared to a control, and in a 12 week old animal there is up-regulation of both mouse opiorphins homologues (mSmr3a and mSmr2) and CD73 (2.5-fold, 4.1-fold and 2.6-fold, respectively).
Sickle cell disease can be viewed as a disease of hypoxia (20) . We have previously shown that in two in vitro models of hypoxia (low oxygen tension and chemical treatment with CoCl 2 ) the rat opiorphin homologue (sialorphin) is up-regulated in rat CSM cells. We extended these studies to demonstrate that hypoxia also regulates CD73 expression in rat CSM cells in vitro. As shown in Figure 1B and 1C, both types of hypoxia caused a significant increase in the level of CD73 protein expressed, and as shown in Figure 3B there was a significant increase in CD73 mRNA when cells were incubated with CoCl 2 to mimic hypoxia.
Sialorphin regulates CD73 expression in a dose and time dependent manner.
We have previously shown that sialorphin can modulate expression of several genes involved in regulation of smooth muscle tone (6, 7). Therefore we investigated if sialorphin might also regulate CD73 expression. We analyzed both the temporal and dose dependence effect of sialorphin on CD73 expression in rat CSM. As shown in Figure 2A , doses of sialorphin from 100-400 800 nM significantly increased CD73 expression in rat CSM cells. In Figure 2B , 400 nM sialorphin significantly increased CD73 expression in a time-dependent manner (24, 48, and 72 determined at 2,4 and 8 hours) and reached a maximum at 8 hours.
Hypoxic upregulation of CD73 expression is dependent on sialorphin expression.
We have previously used siRNA to knock-down the gene encoding sialorphin (vcsa1) expression in CSM cells (7, 16) . We demonstrate in Figure 3A incubation of CSM with increasing amounts of vcsa1-siRNA causes significant down-regulation of vcsa1, such that 10 mM nM vcsa1-siRNA reduced expression by >97% of normal levels. In order to determine that the hypoxic up-regulation of CD73 is dependent on sialorphin, we first knocked-down vcsa1 expression and then incubated cells in hypoxic conditions simulated by CoCl 2 . As shown in Figure 3B and 3C pre-incubation of CSM cells with 10 nM vcsa1-siRNA to knock-down vcsa1 expression for 48 hours prior to exposure to hypoxic conditions for 8 hours prevents the upregulation of both CD73 mRNA ( Figure 3B ) and protein ( Figure 3C ).
DISCUSSION
For the first time we show that both mouse opiorphin homologues and CD73 expression are upregulated in the CSM of sickle cell mice at life-stages both prior to and during the exhibition of priapism. Sickle cell disease is a disease of hypoxia; because of insufficient numbers of erythrocytes for oxygen delivery, sickle cell patients constantly face hypoxic conditions (20) .
Therefore we investigated if similar molecular changes would occur in CSM cells in in vitro models of hypoxia. We demonstrated that hypoxic conditions up-regulate CD73 expression in rat CSM cells, conditions that we have also documented as causing an increase in the expression of the rat opiorphin homologue, sialorphin (7) . We demonstrated that the hypoxic upregulation of CD73 is dependent on the up-regulation of vcsa1, by using vcsa1-siRNA knockdown expression of vcsa1 expression prior to the exposure of CSM cells to hypoxic conditions.
There is increasing evidence that at least in CSM tissue opiorphin is one of the prime regulators of the hypoxic response. Several of the pathways/genes that have previously been shown to be regulated by opiorphin (such as the polyamine pathway(6), A2B and Hif-1a (7)) are related to control of smooth muscle tone. We have proposed that the up-regulation of these genes in response to hypoxia has as the physiologic goal increasing the blood flow into the penis, and thereby reducing hypoxia(7). We propose that it is the excessive activation of these relaxant pathways which leads to priapism. CD73 has previously been shown to be upregulated by hypoxia in intestinal epithelial cells in a Hif-1a dependent manner (21). As described above one of the downstream targets of opiorphin in CSM cells is Hif-1a (7), suggesting that opiorphin activation of CD73 may at least partially be mediated through Hif-1a.
Adenosine accumulates during ischemia and inflammation, a process which is believed to protect tissues from injury (22) . Although several mechanisms might contribute to the protective role of adenosine in hypoxia, adenosine is known to relax vascular smooth muscle tissue causing increased microcirculatory blood flow and thereby oxygenation (23, 24) .
Increased adenosine levels are primarily thought to occur through two mechanisms; inhibition of adenosine kinase and rapid conversion of adenine nucleotides released from cells by ectonucleotidases including CD73. The up-regulation of CD73 we observe both in corpora of animal models of sickle cell disease, and in CSM cells in response to hypoxia, would result in increased local levels of adenosine, which in turn would activate smooth muscle relaxant pathways.
There are 4 adenosine G-protein coupled receptors which bind adenosine, designated A1, A2A, A2B, and A3. While A1 and A3 are associated with G i and inhibit adenylate cyclase activity (25), A2A and A2B are coupled to G s and activate adenylate cyclase (26). Several studies have established that A2A and A2B play an important role in erectile function in both patients and animal models (27) and that activation A2B expression is associated with priapism (9, 10).
In conclusion, the up-regulation of CD73 in the corpora of sickle cell mice, which we report here, would result in higher local levels of adenosine, and when factored with the previously documented activation of A2B (7) (which would lead to greater sensitivity to adenosine levels) would lead to heighted relaxation of CSM tissue. The increased relaxation of the CSM caused by the activation of these pathways would result in increased intracorporal blood-flow and thereby the excessive erectile tendencies associated with priapism. 
TABLES
